PCN5 - Comparative Efficacy And Safety of Olaparib 400 Mg Capsules Bid And Niraparib 300 Mg Tablets QD As Maintenance Treatment After Response To Chemotherapy In Patients with Platinum-Sensitive Relapsed Non-Germline BRCA-Mutated Ovarian Cancer (PSROC). - Sackeyfio, A; Gill, J; Hettle, R; Siddiqui, K; Friedlander, M; Ledermann, JA (Value in Health, 2017)